A Novel C@Fe@Cu Nanocomposite Loaded with Doxorubicin Tailored for the Treatment of Hepatocellular Carcinoma

High mortality and morbidity rates are related to hepatocellular carcinoma (HCC), which is the most prevalent type of liver cancer. A new vision for cancer treatment and cancer cell targeting has emerged with the application of nanotechnology, which reduces the systemic toxicity and adverse effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Saddik, Mohammed S., Elsayed, Mahmoud M. A., Abdel-Rheem, Amany A., El-Mokhtar, Mohamed A., Mosa, Eisa S., Al-Hakkani, Mostafa F., Al-Shelkamy, Samah A., Khames, Ali, Daha, Mohamed A., Abdel-Aleem, Jelan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505246/
https://www.ncbi.nlm.nih.gov/pubmed/36145592
http://dx.doi.org/10.3390/pharmaceutics14091845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505246/
https://www.ncbi.nlm.nih.gov/pubmed/36145592
http://dx.doi.org/10.3390/pharmaceutics14091845

Ejemplares similares